Middle East Dermal Fillers Market is Forecasted to Generate a Revenue of $67.7 Million By 2023: P&S Market Research

NEW YORK, April 16, 2018 (GLOBE NEWSWIRE) — According to the new market research report published by P&S Market Research,  is forecasted to generate a revenue of $67.7 million by 2023, the growth is mainly led by increasing prevalence of skin problems, growing aging population, increasing awareness about age related skin problems, thriving medical tourism industry, and increase in disposable income.

Request to get the free report sample:

On the basis of the type of dermal fillers, the market is categorized into hyaluronic acid-based, hydroxylapatite-based, synthetic polymer-based, and collagen-based fillers. Till now, hyaluronic acid-based fillers have been accounting for the largest share in the dermal fillers market of the Middle East. It is also expected to be the fastest growing category during the forecast period. This can be mainly attributed to the ability of these tissue fillers to attract water molecules, which aids in hydration and increasing skin volume. 

On the basis of application, the dermal fillers market in the Middle East has been segmented into facial line correction, face lift, lip treatment, and others. Facial line correction has been holding the largest share in the dermal fillers market, with an estimated revenue contribution of 45.6% in 2017. It is also expected to be the fastest growing category during the forecast period, due to increasing number of patients opting for this treatment.

Browse report overview with 37 tables and 30 figures spread through 84 pages and detailed TOC on “Middle East Dermal Fillers Market by Type (Hyaluronic Acid-Based, Hydroxylapatite-Based, Synthetic Polymer-Based, Collagen-Based), by Application (Facial Line Correction, Face-Lift, Lip Treatment), by End User (Dermatology Clinics, Hospitals), by Geography (Saudi Arabia, U.A.E) –Market Size, Share, Development, Growth, and Demand Forecast, 2013–2023” at: 

Dermal fillers are used by various end users, such as dermatology clinics, hospitals, and others. Among these, dermatology clinics is the largest end user of tissue fillers in the Middle East and it is also expected to be the fastest growing end user category during the forecast period, owing to the presence of skilled professionals in these clinics for administering these fillers.

Historically, in terms of size, Saudi Arabia has been leading the dermal fillers industry in the Middle East. This can be attributed to growing aging population, increasing demand for cosmetic procedures, and availability of skilled practitioners for dermal filler procedures in the country. According to UNDESA, the proportion of people in Saudi Arabia aged 60 years and above is predicted to be 25% of the total population of 40 million by the end of 2050, leading to the growth of the market in Saudi Arabia, and thereby, maintaining its leading position in the Middle East.

In the Middle East, key players in the dermal fillers industry are launching tissue fillers based on hyaluronic acid to gain a larger market share. For instance, in March 2018, Galderma S.A. in collaboration with AMCo Group and Medica Group, launched two Restylane hyaluronic acid fillers in Saudi Arabia, namely Restylane Refyne and Restylane Defyne. Some of the other major players operating in the dermal fillers market include Allergan plc, Merz Pharma GmbH & Co. KGaA, Sinclair Pharma plc, and Teoxane Laboratories.

More Published Reports by P&S Market Research

Transdermal Drug Delivery Systems Market

The key players in the transdermal drug delivery systems market are acquiring other players to enter in the new business and to launch advanced products to increase their market share. For instance, in November 2016, Luye Pharma Group Ltd, acquired the transdermal drug delivery systems business from Acino International AG, a leading manufacturer of pharmaceuticals in novel drug delivery forms. The acquisition provided Luye Pharma Group. entry into the transdermal drug delivery systems market.

Medication Adherence Market

North America held the largest medication adherence market share in 2016. This large contribution is mainly driven by the increase in R&D infrastructure, growing aging population, expanding healthcare expenditure, and increasing prevalence of chronic diseases in the region. According to the Centers for Disease Control and Prevention (CDC), the total national healthcare expenditure in the U.S. was $3.2 trillion in 2015 and per capita national health expenditure was $9,990.

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research-based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

P&S Market Research

347, 5th Ave. #1402

New York City, NY – 10016

Toll-free: + (USA/Canada)


Connect with us:  |  |  | 

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.